Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tela Bio Inc (NQ: TELA ) 2.460 -0.040 (-1.60%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Tela Bio Inc < Previous 1 2 3 4 Next > The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings March 20, 2022 Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... Via Benzinga Preview: TELA Bio's Earnings March 18, 2022 TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate... Via Benzinga Insiders Buy Around $98M Of 3 Stocks February 25, 2022 Although US stock futures traded lower this morning amid continued Russian bombing in Ukraine, there were a few notable insider trades. W... Via Benzinga TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript November 11, 2021 TELA earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety ROCE Insights For TELA Bio May 24, 2021 In Q1, TELA Bio (NASDAQ:TELA) posted sales of $5.88 million. Earnings were up 7.74%, but TELA Bio still reported an overall loss of $7.27 million. In Q4, TELA Bio brought in $5.67... Via Benzinga The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma August 12, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript August 11, 2021 TELA earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial TELA Bio: Q2 Earnings Insights August 11, 2021 Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which... Via Benzinga Earnings Scheduled For August 11, 2021 August 11, 2021 Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... Via Benzinga The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... Via Benzinga Exposures Product Safety Earnings Outlook For TELA Bio August 10, 2021 On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session June 14, 2021 Gainers RAPT Therapeutics (NASDAQ:RAPT) s... Via Benzinga TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery May 19, 2021 TELA Bio Inc (NASDAQ: TELA) has launched its second post-market study, BRAVO II, to evaluate the clinical performance of OviTex Reinforced Tissue Matrices in the... Via Benzinga TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript May 14, 2021 TELA earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial TELA Bio: Q1 Earnings Insights May 13, 2021 Shares of TELA Bio (NASDAQ:TELA) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 11.11% year over year to ($0.56... Via Benzinga TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript May 03, 2021 TELA earnings call for the period ending December 31, 2020. Via The Motley Fool Topics Earnings Exposures Financial Earnings Scheduled For May 13, 2021 May 13, 2021 Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.